Nanomedicine – prospective therapeutic and diagnostic applications

Nanotechnology, or systems/device manufacture at the molecular level, is a multidisciplinary scientific field undergoing explosive development. The genesis of nanotechnology can be traced to the promise of revolutionary advances across medicine, communications, genomics and robotics. Without doubt, one of the greatest values of nanotechnology will be in the development of new and effective medical treatments (i.e., nanomedicine). This review focuses on the potential of nanomedicine, including the development of nanoparticles for diagnostic and screening purposes, DNA sequencing using nanopores, manufacture of drug delivery systems and single-virus detection.

[1]  Y. Ikada,et al.  Antitumor Effect of Poly(Ethylene Glycol)-Modified Fullerene , 1997 .

[2]  H. Clark,et al.  Optical nanosensors for chemical analysis inside single living cells. 2. Sensors for pH and calcium and the intracellular application of PEBBLE sensors. , 1999, Analytical chemistry.

[3]  Gengfeng Zheng,et al.  Electrical detection of single viruses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Samuel A Wickline,et al.  Nanotechnology for molecular imaging and targeted therapy. , 2003, Circulation.

[5]  S A Wickline,et al.  Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.

[6]  S. Howorka,et al.  Sequence-specific detection of individual DNA strands using engineered nanopores , 2001, Nature Biotechnology.

[7]  Martina Werner,et al.  New disc-based technologies for diagnostic and research applications. , 2002, Psychiatric genetics.

[8]  S A Wickline,et al.  Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. , 2000, Investigative radiology.

[9]  Y. Ikada,et al.  Photodynamic Effect of Polyethylene Glycol–modified Fullerene on Tumor , 1997, Japanese journal of cancer research : Gann.

[10]  J. G. Miller,et al.  A novel site-targeted ultrasonic contrast agent with broad biomedical application. , 1996, Circulation.

[11]  R. Bartus,et al.  Vivitrex®, an Injectable, Extended-Release Formulation of Naltrexone, Provides Pharmacokinetic and Pharmacodynamic Evidence of Efficacy for 1 Month in Rats , 2003, Neuropsychopharmacology.

[12]  D. Deamer,et al.  Nanopores and nucleic acids: prospects for ultrarapid sequencing. , 2000, Trends in biotechnology.

[13]  Fariba Dehghani,et al.  Generation of Micro-Particles of Proteins for Aerosol Delivery Using High Pressure Modified Carbon Dioxide , 2000, Pharmaceutical Research.

[14]  John Samuel,et al.  Analysis of Poly(D,L-Lactic-Co-Glycolic Acid) Nanosphere Uptake by Human Dendritic Cells and Macrophages In Vitro , 2002, Pharmaceutical Research.

[15]  J. G. Miller,et al.  In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. , 1998, The Journal of the Acoustical Society of America.

[16]  Huan-Yao Lei,et al.  Inhibition of Escherichia coli-Induced Meningitis by Carboxyfullerence , 1999, Antimicrobial Agents and Chemotherapy.

[17]  Kerry K. Karukstis,et al.  Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis , 2002, Circulation.

[18]  Donald E. Chickering,et al.  Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.

[19]  P Yager,et al.  Testosterone delivery using glutamide-based complex high axial ratio microstructures. , 2001, Bioorganic & medicinal chemistry.

[20]  W. Heckl,et al.  Nanotechnology and medicine , 2004, 4th IEEE Conference on Nanotechnology, 2004..

[21]  Ralph Weissleder,et al.  Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. , 2002, Bioconjugate chemistry.

[22]  Robert Langer,et al.  Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres , 1991, Pharmaceutical Research.

[23]  M. Prato,et al.  Antimycobacterial activity of ionic fullerene derivatives. , 2000, Bioorganic & medicinal chemistry letters.

[24]  R. Lockey,et al.  Nanoparticle-mediated gene delivery: state of the art , 2004, Expert opinion on biological therapy.

[25]  Yee‐Shin Lin,et al.  Inhibition of Group A Streptococcus Infection by Carboxyfullerene , 2001, Antimicrobial Agents and Chemotherapy.

[26]  H E Junginger,et al.  In Vivo Uptake of Chitosan Microparticles by Murine Peyer's Patches: Visualization Studies using Confocal Laser Scanning Microscopy and Immunohistochemistry , 2001, Journal of drug targeting.

[27]  Matsuhiko Nishizawa,et al.  Metal Nanotubule Membranes with Electrochemically Switchable Ion-Transport Selectivity , 1995, Science.

[28]  Stasia A. Anderson,et al.  Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles , 2000 .

[29]  R F Schinazi,et al.  Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene , 1993, Antimicrobial Agents and Chemotherapy.

[30]  M. Einarson.  Controlled-release microchip , 1999, Nature Biotechnology.

[31]  R. Shohet,et al.  DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. , 2002, Ultrasound in medicine & biology.

[32]  H. Dai,et al.  Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. , 2001, Journal of the American Chemical Society.

[33]  N Hussain,et al.  Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. , 2001, Advanced drug delivery reviews.

[34]  Michael J McShane,et al.  Potential for glucose monitoring with nanoengineered fluorescent biosensors. , 2002, Diabetes technology & therapeutics.

[35]  E. Unger,et al.  Therapeutic applications of microbubbles. , 2002, European journal of radiology.

[36]  Sheng-Kwei Song,et al.  High‐resolution MRI characterization of human thrombus using a novel fibrin‐targeted paramagnetic nanoparticle contrast agent , 2000, Magnetic resonance in medicine.

[37]  E. Albina,et al.  Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment. , 2000, International journal of pharmaceutics.

[38]  C H Lorenz,et al.  Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. , 1998, Academic radiology.

[39]  Fernando Otero,et al.  Correlation between myocardial perfusion abnormalities detected with intermittent imaging using intravenous perfluorocarbon microbubbles and radioisotope imaging during high‐dose dipyridamole stress echo , 2002, Clinical cardiology.

[40]  J L West,et al.  A whole blood immunoassay using gold nanoshells. , 2003, Analytical chemistry.

[41]  C. R. Martin,et al.  The emerging field of nanotube biotechnology , 2003, Nature Reviews Drug Discovery.

[42]  M. Márquez,et al.  Micro/Nano Encapsulation via Electrified Coaxial Liquid Jets , 2002, Science.

[43]  D. Branton,et al.  Rapid nanopore discrimination between single polynucleotide molecules. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Clark,et al.  Optical nanosensors for chemical analysis inside single living cells. 1. Fabrication, characterization, and methods for intracellular delivery of PEBBLE sensors. , 1999, Analytical chemistry.

[45]  Raoul Kopelman,et al.  A fluorescent PEBBLE nanosensor for intracellular free zinc. , 2002, The Analyst.

[46]  R M Albrecht,et al.  Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. , 2001, Journal of pharmaceutical sciences.

[47]  Wolfgang Fritzsche,et al.  Gold nanoparticles as novel label for DNA diagnostics , 2002, Expert review of molecular diagnostics.